Head-To-Head Comparison: Integrated BioPharma (OTCMKTS:INBP) versus NovAccess Global (OTCMKTS:XSNX)

Earnings and Valuation

This table compares Integrated BioPharma and NovAccess Global”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integrated BioPharma	$50.32 million	0.19	$110,000.00	$0.02	16.06
NovAccess Global	N/A	N/A	-$4.72 million	($0.11)	0.00

Integrated BioPharma has higher revenue and earnings than NovAccess Global. NovAccess Global is trading at a lower price-to-earnings ratio than Integrated BioPharma, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

25.3% of Integrated BioPharma shares are owned by institutional investors. 67.2% of Integrated BioPharma shares are owned by company insiders. Comparatively, 1.4% of NovAccess Global shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Integrated BioPharma and NovAccess Global’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Integrated BioPharma	0.84%	2.26%	1.64%
NovAccess Global	N/A	N/A	-1,723.92%

Risk and Volatility

Integrated BioPharma has a beta of 0.59, meaning that its share price is 41% less volatile than the S&P 500. Comparatively, NovAccess Global has a beta of 2.19, meaning that its share price is 119% more volatile than the S&P 500.

Summary

Integrated BioPharma beats NovAccess Global on 9 of the 10 factors compared between the two stocks.

About Integrated BioPharma

Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.

About NovAccess Global

NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient’s immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.